• Health & Medicine

6 highlights from our Black in Cancer conference

Many cancers affect Black people differently. Often, their outcomes are worse. There's a long way to go to change that, but this is how we can start. Many cancers affect Black people differently. Often, their outcomes are worse. There's a long way to go to change that, but this is how we can start.

31 October 2022

• Health & Medicine

New treatment for Waldenstrom’s macroglobulinaemia in England

1 October 2022

• For Researchers

A coming together of minds for early detection

We catch up with Dr Alexis Webb and find out about the upcoming Early Detection of Cancer Conference, the importance of collaboration and why these are exciting times for the field... We catch up with Dr Alexis Webb and find out about the upcoming Early Detection of Cancer Conference, the importance of collaboration and why these are exciting times for the field...

18 August 2022

• Personal Stories

How serendipity sent this oncologist in search of a cure for cancer

Dr Hugo De La Peña, the face of our latest TV advert, explains how a second chance at life led to a career dedicated to curing cancer.   Dr Hugo De La Peña, the face of our latest TV advert, explains how a second chance at life led to a career dedicated to curing cancer.  

12 August 2022

• Health & Medicine

COVID-19 vaccine and cancer – latest updates

Recently, news of a COVID-19 vaccine has dominated headlines. We've summarised all the information that is out there, with rolling updates, in our new vaccine blog post. Recently, news of a COVID-19 vaccine has dominated headlines. We've summarised all the information that is out there, with rolling updates, in our new vaccine blog post.

18 July 2022

• For Researchers

Joining the dots: How our new research data strategy will unlock the power of big data

To capitalise on the reams of data produced by cancer researchers we must have a joined up approach - here's how our new strategy will help To capitalise on the reams of data produced by cancer researchers we must have a joined up approach - here's how our new strategy will help

7 July 2022

• Health & Medicine

NICE doesn’t recommend ibrutinib drug for those with Waldenstrom’s macroglobulinaemia

Ibrutinib, a drug used to treat Waldenstrom’s macroglobulinaemia, is not being recommended by the National Institute for Health and Care Excellence in England Ibrutinib, a drug used to treat Waldenstrom’s macroglobulinaemia, is not being recommended by the National Institute for Health and Care Excellence in England

23 May 2022

• Health & Medicine

Immune cell count could determine whether chemotherapy is required in oropharyngeal cancer, new study finds 

A new study has found that the level of a person's immune cells may provide an indication of whether they would benefit from chemotherapy in oropharyngeal cancer. A new study has found that the level of a person's immune cells may provide an indication of whether they would benefit from chemotherapy in oropharyngeal cancer.

2 May 2022

• Health & Medicine

Triple negative breast cancer drug given initial ‘no’ for NHS in England

Sacituzumab govitecan (Trodelvy) is not being recommended by NICE for use in England as a treatment for some people with triple-negative breast cancer. Sacituzumab govitecan (Trodelvy) is not being recommended by NICE for use in England as a treatment for some people with triple-negative breast cancer.

8 April 2022

• Health & Medicine

120 years of discovery: 10 ways we’ve changed the story for people with cancer

From a legacy of life-saving medicines to developing new tools to detect cancer, our scientists have been at the forefront of cancer research for 120 years. From a legacy of life-saving medicines to developing new tools to detect cancer, our scientists have been at the forefront of cancer research for 120 years.

2 February 2022